Quarterly report pursuant to Section 13 or 15(d)

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.10.0.1
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 9 Months Ended
Jan. 01, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Accounting Policies [Abstract]            
Research and Development Expense   $ 744,173 $ 1,124,506 $ 3,056,101 $ 3,802,149  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)   3,358,130   3,358,130   3,404,131
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares)   3,069,996   3,069,996   2,938,995
Registration Payment Arrangement, Accrual Carrying Value   $ 0   $ 0    
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity $ 3,044,162